David C Griffith
6PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 15, 2025
Phase 1, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the safety, tolerability, and pharmacokinetics of intravenous xeruborbactam (QPX7728) in healthy adult subjects.María Patricia Hernández-Mitre, Steven C Wallis, Jeffery S Loutit
|Dec 09, 2024
Phase 1 study of the safety, tolerability, and pharmacokinetics of a synthetic macrocyclic peptide antibiotic (BRII-693) in healthy adult participants.Michael Watkins, Yali Zhu, David C Griffith
|Dec 07, 2023
A phase I, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the pharmacokinetics, safety, and tolerability of oral ceftibuten in healthy adult subjects.María Patricia Hernández-Mitre, Steven C Wallis, Elizabeth E Morgan
|Nov 14, 2022
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility Breakpoints.S M Bhavnani, M Trang, D C Griffith
|Mar 09, 2021
A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Biapenem in Healthy Adult Subjects.David C Griffith, Elizabeth E Morgan, Michael N Dudley
|Aug 26, 2020
In Vivo Activity of QPX7728, an Ultrabroad-Spectrum Beta-Lactamase Inhibitor, in Combination with Beta-Lactams against Carbapenem-Resistant Klebsiella pneumoniae.Mojgan Sabet, Ziad Tarazi, David C Griffith
Pageof 1
Frequent Collaborators
2 joint publications
María Patricia Hernández-Mitre
2 joint publications
Jason A Roberts
1 joint publications
S M Bhavnani
1 joint publications
M Trang
1 joint publications
O Lomovskaya
1 joint publications
P G Ambrose
1 joint publications
C M Rubino
1 joint publications
Michael Watkins
1 joint publications
Steven C Wallis
